Fruquintinib With mFOLFOX6/FOLFIRI as First-Line Therapy for Conversion Surgery in mCRC
Clinical trial NCT06010888 · UNKNOWN
Trial details
- NCT number
- NCT06010888
- Sponsor
- Fudan University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-31
- Primary completion
- 2024-10-31
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.